Penumbra Inc (PEN)
As of Sep 20, 2026, Penumbra Inc (PEN) scores 4.1/10 on AlphaStocks' five-model composite, #138 of 168 Health Care stocks.
Health Care / Health Care Equipment
S&P MidCap 400$317.56
Below average on several measures. Research carefully.
Weak
Score based on 3 of 5 models — moderate confidence
Data as of Sep 20, 2026
Is Penumbra Inc a Good Investment in 2026?
Penumbra Inc (PEN) scores 4.1 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates Penumbra Inc as Attractive (6/9). However, the Graham model rates it Caution — Significantly above fair value. Penumbra Inc ranks #138 out of 168 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Trades at 70x earnings — above sector median of 30x.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
6/9
Buffett
Attractive
Business quality & competitive moat
Graham
Caution
Significantly above fair value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Limited Data
Earnings yield + return on capital
Frequently Asked Questions
Is Penumbra Inc (PEN) a good investment?
What is Penumbra Inc's Piotroski F-Score?
Is PEN overvalued or undervalued?
How does PEN compare to other Health Care stocks?
What do investment models say about PEN?
Similar Stocks
Compare PEN with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer